153 related articles for article (PubMed ID: 15062057)
21. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
23. Effects of loss-of-function and gain-of-function mutations of c-kit on the gastrointestinal tract.
Hirota S; Isozaki K; Nishida T; Kitamura Y
J Gastroenterol; 2000; 35 Suppl 12():75-9. PubMed ID: 10779223
[TBL] [Abstract][Full Text] [Related]
24. Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis.
Willmore C; Holden JA; Zhou L; Tripp S; Wittwer CT; Layfield LJ
Am J Clin Pathol; 2004 Aug; 122(2):206-16. PubMed ID: 15323137
[TBL] [Abstract][Full Text] [Related]
25. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
[TBL] [Abstract][Full Text] [Related]
26. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors.
Ernst SI; Hubbs AE; Przygodzki RM; Emory TS; Sobin LH; O'Leary TJ
Lab Invest; 1998 Dec; 78(12):1633-6. PubMed ID: 9881963
[TBL] [Abstract][Full Text] [Related]
27. Prognostic assessment of gastrointestinal stromal tumor.
Yan H; Marchettini P; Acherman YI; Gething SA; Brun E; Sugarbaker PH
Am J Clin Oncol; 2003 Jun; 26(3):221-8. PubMed ID: 12796588
[TBL] [Abstract][Full Text] [Related]
28. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumors.
Yamaguchi M; Tate G; Endo Y; Miyaki M
Hepatogastroenterology; 2003; 50(53):1431-5. PubMed ID: 14571755
[TBL] [Abstract][Full Text] [Related]
30. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
[TBL] [Abstract][Full Text] [Related]
31. [Expression and clinical significance of c-kit oncogene in gastrointestinal stromal tumors].
Liu X; Ma D; Wu L; Bai C; Hu H
Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):277-9. PubMed ID: 12133359
[TBL] [Abstract][Full Text] [Related]
32. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors.
Singer S; Rubin BP; Lux ML; Chen CJ; Demetri GD; Fletcher CD; Fletcher JA
J Clin Oncol; 2002 Sep; 20(18):3898-905. PubMed ID: 12228211
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors.
Kim TW; Lee H; Kang YK; Choe MS; Ryu MH; Chang HM; Kim JS; Yook JH; Kim BS; Lee JS
Clin Cancer Res; 2004 May; 10(9):3076-81. PubMed ID: 15131046
[TBL] [Abstract][Full Text] [Related]
35. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation.
Choi YR; Kim H; Kang HJ; Kim NG; Kim JJ; Park KS; Paik YK; Kim HO; Kim H
Cancer Res; 2003 May; 63(9):2188-93. PubMed ID: 12727838
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
38. Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y.
Thalheimer A; Schlemmer M; Bueter M; Merkelbach-Bruse S; Schildhaus HU; Buettner R; Hartung E; Thiede A; Meyer D; Fein M; Maroske J; Wardelmann E
Am J Surg Pathol; 2008 Oct; 32(10):1560-5. PubMed ID: 18724244
[TBL] [Abstract][Full Text] [Related]
39. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
[TBL] [Abstract][Full Text] [Related]
40. c-kit Mutation in generalized lentigines associated with gastrointestinal stromal tumor.
Shibusawa Y; Tamura A; Mochiki E; Kamisaka K; Kimura H; Ishikawa O
Dermatology; 2004; 208(3):217-20. PubMed ID: 15118370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
